midterm Flashcards

1
Q

Descriptive epidemiology

A

Classify according to person, place and time variables

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

analytical epidemiology

A

explores causal hypotheses between exposures and health conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Simple random sampling (SRS)

A

sample is selected using random processes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

stratified random sampling

A

to ensure adequate representation of minority groups that might be underrepresented in SRS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

convenience sampling

A

selecting individuals from easily accessible and available groups such as those who visit a specific clinic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Systematic sampling

A

choosing via a systematic, predetermined approach from the sampling frame

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cluster sampling

A

selecting groups of individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Central tendency

A

in normal distribution, mean, median and mode are equal and situated at center of distribution with values symmetrically distributed around central point

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

skewed distribution

A

mean, median and mode are often different- median is most accurate because it is resistant to outliers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

symmetric distribution

A

mean and median are equivalent- mean is preferred bc it is more stable/precise across different sample sizes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Multimodal distribution

A

several peaks in frequency of data marking distinct groups/clusters within dataset (ex. Age-related changes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Epidemic curve

A

represents distribution of cases over specified time frame to identity patterns in disease outbreaks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Dose-response curve

A

correlation between exposure and effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Incidence

A

number of new cases occurring in specific population in specific time period

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prevalence

A

total number of existing cases in population at specific time, expressed as proportion, New cases and treatment advances that extend survival can boost prevalence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

person variables

A

Age, sex, race, socioeconomic status, marital status

17
Q

place variables

A

Morbidity and mortality influenced by geographic factors (ie life expectancy), urban vs rural, localized patterns of disease

18
Q

time variables

A

Secular trends (long-term changes in frequency of diseases), cyclic (seasonal) trends, point epidemics, clustering

19
Q

Criteria for causal relationship

A

Strength of association
Consistency
Specificity
Temporality- establishing that exposure occurs before health outcome
Biological gradient- depicting how increased exposure correlates with increased disease incidence
Plausibility
Coherence
Experimental evidence
Analogy in causality- comparison against established causal relationships

20
Q

Risk factor

A

Factors correlated with an increased likelihood of disease but are not sufficient on their own to cause it

21
Q

observational studies

A

ecological, case-control, cohort, cross-sectional

22
Q

experimental studies

A

clinical trials, field trials, community trials
Advantages: less prone to biases, control for confounding variables, causal relationships
Disadvantages: complex and costly, large sample size, ethical considerations, patient non-compliance

23
Q

bias

A

Systematic error that leads to deviation from truth

24
Q

Hawthorne effect

A

altered behavior bc know they’re being studied

25
Q

Recall bias

A

remembering exposure history

26
Q

Selection bias

A

selecting participants leads to misrepresentation of association between exposure and outcome

27
Q

ecological studies

A

estimate exposure levels for groups based on data from environment, applying same exposure level to all group members despite variations within group
Advantages: broader context, conducted quickly with less resources because data is more readily available, useful when cant get individual level data
Disadvantages: ecologic fallacy- correlations at group do not necessarily apply to individuals, overlook individual/personal behaviors and genetic predispositions

28
Q

case-control studies

A

cases have outcome/disease, retrospective approach
Advantages: useful for studying low-prevalence conditions or rare diseases, fewer resources and quicker than traditional follow up studies
Disadvantages: innacurate exposure measurements, representativeness of cases and controls may be uncertain, indirect estimates of risk, temporal relationships may not be clear

29
Q

cohort studies

A

tracks incidence overtime following cohort that shares common characteristic
Fixed- individuals classified as exposed or unexposed at specific baseline time and followed
Dynamic- continuous recruitment of new eligible candidates over time- inds may shift from unexposed to exposed group
Advantages- evaluating incidence rates, direct observation of risk, relationship between exposure and outcomes over time, uncommon exposures or diseases with clear temporal relationships between exposures and outcomes
Disadvantages- costly and time consuming, not useful in rare conditions, planning and tracking large groups, non-participation may affect demographics

30
Q

cross-sectional studies

A

examines defined population or random sample at specific point in time- assessing both presence of disease and potential determinants, mainly descriptive (not causal relationships)
Advantages: snapshot, inexpensive and easy bc do not follow over time
Disadvantages: establishing causal, controlling for confounding variables, accurate reporting of exposure by patients, selection bias, length bias

31
Q

clinical trials- randomized controlled trials (RCTs)

A

phase 1 tests safety, phase 2 immune responses and phase 3 randomization
randomly allocated into test and control groups

32
Q

field trials and community trials

A

involve healthy individuals at risk, data collection in natural settings, evaluate intervention designed to prevent diseases
involve groups, can be harder

33
Q

environmental epidemiology

A

etiology (causes/origins), natural history, health status of pop, effectiveness of interventions, geographic focus

34
Q

Natural history of disease

A

Pathological onset, presymptomatic stage, clinical stage
Prognosis- predicting likely course of disease
Efficacy- benefits of treatment under ideal conditions
Effectiveness- benefits in real-world clinical settings (RCTs)

35
Q

dose-effect/dose-response relationship

A

Does-effect identify which adverse effects should be prioritized for prevention
Dose-response to determine what constitutes acceptable level for exposure

36
Q

directed acyclic graphs (DAGs)

A

relationships/causal links (arrows) between variables (nodes), no sequence of arrows forms a closed loop, if 2 or more variables share same cause (“parent” cause should be included), unmeasured confounding/cause (arrow pointing both directions between 2 nodes)